Adeno-Associated Virus as an Effective Malaria Booster Vaccine Following Adenovirus Priming

An ideal malaria vaccine platform should potently induce protective immune responses and block parasite transmission from mosquito to human, and it should maintain these effects for an extended period. Here, we have focused on vaccine development based on adeno-associated virus serotype 1 (AAV1), a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yusuf, Yenni, Yoshii, Tatsuya, Iyori, Mitsuhiro, Yoshida, Kunitaka, Mizukami, Hiroaki, Fukumoto, Shinya, Yamamoto, Daisuke S., Alam, Asrar, Emran, Talha Bin, Amelia, Fitri, Islam, Ashekul, Otsuka, Hiromu, Takashima, Eizo, Tsuboi, Takafumi, Yoshida, Shigeto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460511/
https://www.ncbi.nlm.nih.gov/pubmed/31024558
http://dx.doi.org/10.3389/fimmu.2019.00730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460511/
https://www.ncbi.nlm.nih.gov/pubmed/31024558
http://dx.doi.org/10.3389/fimmu.2019.00730

Ejemplares similares